Antibodies to Plasmodium circumsporozoite protein (CSP) inhibit sporozoite's cell traversal activity
- PMID: 22306356
- PMCID: PMC3310221
- DOI: 10.1016/j.jim.2012.01.009
Antibodies to Plasmodium circumsporozoite protein (CSP) inhibit sporozoite's cell traversal activity
Abstract
Plasmodium sporozoites are deposited in the skin of the mammalian host by Anopheles mosquitoes. To continue the life cycle, the sporozoites have to invade the host's hepatocytes, where they transform into exoerythrocytic forms (EEFs) inside a parasitophorous vacuole. During their route from the skin to the liver, the parasites traverse the capillary epithelium in the dermis to enter the blood circulation, and cross the endothelium of liver sinusoids to enter the parenchyma. Cell traversal by sporozoites is usually measured by quantifying dyes that enter or are released from cells during incubation with salivary gland sporozoites. These methods do not distinguish cell traversal from cell wounding. Here we validate an assay that quantifies cell traversal of sporozoites through monolayers of MDCK cells that form tight junctions. We compared cell traversal of wt sporozoites and of parasites lacking the Type I membrane protein TLP (TRAP-like protein) previously implicated in cell traversal. We provide direct evidence that TLP ko sporozoites are defective in cell traversal and that they are retained inside the MDCK cytoplasm. We then used the MDCK assay to study the effect of a monoclonal antibody (3D11) to the circumsporozoite protein (CSP) on the parasite's cell traversal. We show that 3D11 inhibits cell traversal at nanomolar concentrations. We conclude that antibodies elicited by CSP-based vaccines are likely to inhibit the migration of sporozoites from the skin to the liver.
Copyright © 2012 Elsevier B.V. All rights reserved.
Figures



Similar articles
-
Late killing of Plasmodium berghei sporozoites in the liver by an anti-circumsporozoite protein antibody.Elife. 2025 Feb 14;14:RP105291. doi: 10.7554/eLife.105291. Elife. 2025. PMID: 39951341 Free PMC article.
-
Cytotoxic anti-circumsporozoite antibodies target malaria sporozoites in the host skin.Nat Microbiol. 2018 Nov;3(11):1224-1233. doi: 10.1038/s41564-018-0254-z. Epub 2018 Oct 22. Nat Microbiol. 2018. PMID: 30349082
-
Structural ordering of the Plasmodium berghei circumsporozoite protein repeats by inhibitory antibody 3D11.Elife. 2020 Nov 30;9:e59018. doi: 10.7554/eLife.59018. Elife. 2020. PMID: 33253113 Free PMC article.
-
Plasmodium sporozoites on the move: Switching from cell traversal to productive invasion of hepatocytes.Mol Microbiol. 2021 May;115(5):870-881. doi: 10.1111/mmi.14645. Epub 2020 Dec 5. Mol Microbiol. 2021. PMID: 33191548 Free PMC article. Review.
-
Plasmodium sporozoite-host interactions from the dermis to the hepatocyte.Curr Opin Microbiol. 2009 Aug;12(4):401-7. doi: 10.1016/j.mib.2009.06.006. Epub 2009 Jul 14. Curr Opin Microbiol. 2009. PMID: 19608456 Free PMC article. Review.
Cited by
-
Pathogenicity and virulence of malaria: Sticky problems and tricky solutions.Virulence. 2023 Dec;14(1):2150456. doi: 10.1080/21505594.2022.2150456. Virulence. 2023. PMID: 36419237 Free PMC article. Review.
-
A mosquito salivary gland protein partially inhibits Plasmodium sporozoite cell traversal and transmission.Nat Commun. 2018 Jul 25;9(1):2908. doi: 10.1038/s41467-018-05374-3. Nat Commun. 2018. PMID: 30046053 Free PMC article.
-
Mechanisms and targets of Fcγ-receptor mediated immunity to malaria sporozoites.Nat Commun. 2021 Mar 19;12(1):1742. doi: 10.1038/s41467-021-21998-4. Nat Commun. 2021. PMID: 33741975 Free PMC article.
-
Rare PfCSP C-terminal antibodies induced by live sporozoite vaccination are ineffective against malaria infection.J Exp Med. 2018 Jan 2;215(1):63-75. doi: 10.1084/jem.20170869. Epub 2017 Nov 22. J Exp Med. 2018. PMID: 29167197 Free PMC article.
-
The Search of a Malaria Vaccine: The Time for Modified Immuno-Potentiating Probes.Vaccines (Basel). 2021 Feb 2;9(2):115. doi: 10.3390/vaccines9020115. Vaccines (Basel). 2021. PMID: 33540947 Free PMC article. Review.
References
-
- Agnandji, et al. First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children. N. Engl. J. Med. 2011;365:1863–1875. - PubMed
-
- Amino R, Giovannini D, Thiberge S, Gueirard P, Boisson B, Dubremetz JF, Prevost MC, Ishino T, Yuda M, Menard R. Host cell traversal is important for progression of the malaria parasite through the dermis to the liver. Cell Host Microbe. 2008;3:88–96. - PubMed
-
- Barragan A, Brossier F, Sibley LD. Transepithelial migration of Toxoplasma gondii involves an interaction of intercellular adhesion molecule 1 (ICAM-1) with the parasite adhesin MIC2. Cell. Microbiol. 2005;7:561–568. - PubMed
-
- Bruña-Romero O, Hafalla JC, González-Aseguinolaza G, Sano G, Tsuji M, Zavala F. Detection of malaria liver-stages in mice infected through the bite of a single Anopheles mosquito using a highly sensitive real-time PCR. Int. J. Parasitol. 2001;31:1499–1502. - PubMed
-
- Carruthers VB, Sibley LD. Sequential protein secretion from three distinct organelles of Toxoplasma gondii accompanies invasion of human fibroblasts. Eur. J. Cell. Biol. 1997;73:114–123. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials